>>11613416[...] That’s a drug that the president has directed us to take a closer look at as to whether an expanded use approach to that could be done to actually see if that benefits patients. And again, we want to do that in the setting of a clinical trial, a large pragmatic clinical trial to actually gather that information and answer the question that needs to be asked and answered.
Reporter
>I wanted to ask about remdesivir [...] Can you say, is it currently approved for use on the virus?Dr. Hahn
>It is currently in clinical trials here and around the world. We have also made it available by that approach that I told you called, compassionate use, where a doctor could ask the FDA for that. And the really positive thing about that, that gives it rapidly to a doctor and a patient. But it allows us to collect the data because what we really need to do is understand what the data and science are in order to make the appropriate decision about safety and effectiveness.Now that you’ve read this, I shouldn’t have to state the obvious, but I will: to say that Trump claimed this was an approved treatment for COVID-19 specifically, is a false statement. The flaw is in adding the qualifier “for COVID-19” and then, as coronavirus treatments are the subject of the briefing, superimposing the assumption that any reference to the status of a drug having been approved is, specifically, a reference to it having been approved as a successful and safe treatment for COVID-19. Essentially, you are fact-checking falsities stemming from your own misunderstanding. This is also true for the other two claims you made, which are similarly confused.
[3/3]
